Liver Function Tests (LFTs) Panel: ALT, AST, ALP, GGT, Bilirubin, Albumin, and Results

Liver function tests are a group of blood tests that help show whether the liver is irritated, injured, blocked, or struggling to make important proteins. A typical LFT panel includes liver enzymes such as ALT, AST, ALP, and sometimes GGT, along with bilirubin and albumin. These numbers are often ordered during routine checkups, before or during certain medications, or when symptoms such as fatigue, nausea, itching, dark urine, pale stools, abdominal swelling, or yellowing of the skin suggest a liver or bile duct problem.

The name “liver function tests” can be a little misleading. ALT, AST, ALP, and GGT mostly show liver or bile duct injury, not how well the liver is working. Albumin, bilirubin, and sometimes PT/INR are closer to true liver function. The most useful interpretation comes from the pattern of results, the degree of abnormality, symptoms, medications, alcohol use, metabolic risk, and whether the changes persist.

• LFTs usually include ALT, AST, ALP, bilirubin, albumin, and sometimes GGT, total protein, and PT/INR.
• ALT and AST mainly reflect liver cell irritation or injury; ALT is more liver-specific, while AST can also rise from muscle injury.
• ALP and GGT help point toward bile duct or cholestatic patterns; ALP can also rise from bone sources.
• Bilirubin helps explain jaundice patterns; direct bilirubin often points toward liver or bile duct disease, while indirect bilirubin can come from red blood cell breakdown or Gilbert syndrome.
• Albumin is made by the liver, but low albumin can also come from kidney loss, inflammation, malnutrition, or serious illness.
• Markedly abnormal results, jaundice, confusion, easy bleeding, severe abdominal pain, fever, or very dark urine need prompt medical attention.

Table of Contents

• What Liver Function Tests Measure
• Normal Ranges and Common Markers
• Patterns of Abnormal Results
• High ALT and AST
• High ALP, GGT, and Bilirubin
• Albumin and True Liver Function
• What to Do After Abnormal LFTs
• When Results Need Urgent Care

What Liver Function Tests Measure

Liver function tests measure substances in the blood that change when liver cells are injured, bile flow is blocked, or the liver’s protein-making ability is reduced. The panel is useful because liver disease does not always cause symptoms early. A person can feel normal and still have elevated enzymes, fatty liver, viral hepatitis, alcohol-related liver stress, medication-related injury, or bile duct disease.

Most LFT panels include a mix of enzymes, pigments, and proteins:

• ALT, or alanine aminotransferase, is an enzyme found mostly in liver cells.
• AST, or aspartate aminotransferase, is found in the liver but also in muscle, heart, and red blood cells.
• ALP, or alkaline phosphatase, is found in bile duct cells, bone, intestine, and placenta.
• GGT, or gamma-glutamyl transferase, is often used with ALP to help decide whether high ALP is more likely from the liver or from bone.
• Bilirubin is a yellow pigment made when the body breaks down old red blood cells.
• Albumin is a major blood protein made by the liver.
• Total protein and globulin may appear with albumin and can help show inflammation, immune activation, or protein balance.
• PT/INR is not always part of a basic liver panel, but it is important when clinicians need to know whether the liver is making clotting factors well.

A helpful way to read the panel is to separate injury markers from function markers. ALT and AST rise when liver cells leak enzymes into the blood. ALP and GGT rise when bile ducts or bile flow are irritated. Bilirubin rises when bilirubin production, processing, or drainage is disrupted. Albumin and PT/INR reflect the liver’s synthetic function, meaning its ability to make proteins the body needs.

This distinction matters. A person can have very high ALT and AST during acute liver irritation while albumin remains normal because albumin changes more slowly. Another person can have only mild enzyme elevations but low albumin and a high INR if advanced chronic liver disease has reduced the liver’s ability to make proteins. For a broader panel that includes liver, kidney, electrolyte, and metabolic markers, a comprehensive metabolic panel may provide useful context.

Normal Ranges and Common Markers

Reference ranges vary by laboratory, age, sex, pregnancy status, medications, and testing method. The ranges below are common adult examples, not universal cutoffs. The lab’s own reference interval should be used first, and a clinician may still investigate a result that falls within the printed “normal” range if the pattern, symptoms, or risk factors are concerning.

Marker	What it mainly reflects	Common adult reference range	Common meaning when high or low
ALT	Liver cell injury or irritation	About 7–55 U/L	High ALT often points to liver cell injury from fatty liver, viral hepatitis, alcohol, medications, toxins, or inflammation.
AST	Liver or muscle injury	About 8–48 U/L	High AST can come from liver disease, alcohol-related liver injury, muscle damage, strenuous exercise, or hemolysis.
ALP	Bile duct activity, bone turnover	About 40–130 U/L	High ALP may suggest bile duct obstruction, cholestasis, liver infiltration, bone growth, bone disease, or pregnancy-related changes.
GGT	Liver and bile duct irritation	Often about 8–61 U/L, depending on lab and sex	High GGT supports a liver or bile duct source for high ALP and may rise with alcohol use, fatty liver, medications, or bile duct disease.
Total bilirubin	Bilirubin production, liver processing, bile drainage	About 0.1–1.2 mg/dL	High bilirubin can cause jaundice and may come from liver disease, bile duct blockage, hemolysis, or Gilbert syndrome.
Direct bilirubin	Conjugated bilirubin handled by the liver	Often 0–0.3 mg/dL	High direct bilirubin often suggests liver cell disease or impaired bile flow.
Albumin	Liver protein production and overall protein balance	About 3.5–5.0 g/dL	Low albumin can occur with chronic liver disease, kidney protein loss, inflammation, malnutrition, or severe illness.

Small deviations are common and often temporary. A mild ALT elevation after a viral illness, a hard workout, alcohol intake, or a medication change does not have the same meaning as a persistent elevation over months. Results also need context. For example, ALP is normally higher in growing children and adolescents because of bone growth. Pregnancy can raise ALP because the placenta makes an ALP form. AST can rise after intense exercise because skeletal muscle contains AST.

The degree of elevation helps guide urgency. Mild elevations are often less than 2–3 times the upper limit of normal. Moderate elevations are higher and more likely to need structured follow-up. Very high ALT or AST, especially in the hundreds or thousands, raises concern for acute hepatitis, severe drug or toxin injury, ischemic liver injury, or other acute liver cell damage.

Normal results also do not rule out every liver problem. Fatty liver, early fibrosis, chronic viral hepatitis, and even cirrhosis can sometimes appear with normal or near-normal enzymes. When risk is high, clinicians may use additional tests such as hepatitis screening, ultrasound, elastography, platelet count, ferritin and iron studies, autoimmune markers, or fibrosis scores such as FIB-4.

Patterns of Abnormal Results

The pattern of abnormal LFTs is often more useful than any single number. Clinicians usually compare ALT and AST with ALP and bilirubin to decide whether the pattern looks hepatocellular, cholestatic, mixed, or more related to liver function.

A hepatocellular pattern means ALT and AST are more elevated than ALP. This pattern suggests liver cell irritation or injury. Common causes include metabolic dysfunction-associated steatotic liver disease, viral hepatitis, alcohol-related liver injury, autoimmune hepatitis, hemochromatosis, Wilson disease in younger people, alpha-1 antitrypsin deficiency, and medication or supplement injury.

A cholestatic pattern means ALP is more elevated than ALT and AST, often with high GGT and sometimes high direct bilirubin. Cholestasis means bile is not flowing normally. Causes include gallstones, bile duct narrowing, primary biliary cholangitis, primary sclerosing cholangitis, pancreatic or bile duct tumors, medication reactions, infiltrative liver disease, and severe sepsis.

A mixed pattern has both enzyme groups elevated. This can happen with drug-induced liver injury, viral hepatitis with bile flow impairment, alcohol-related hepatitis, gallstone disease, or overlapping conditions. A mixed pattern needs careful medication, supplement, alcohol, symptom, and imaging review.

A synthetic dysfunction pattern involves low albumin, high PT/INR, or both. This may suggest reduced liver protein-making ability, especially in advanced liver disease, but albumin is not liver-specific. Kidney disease, protein-losing gut conditions, inflammation, burns, malnutrition, and severe illness can also lower albumin.

The pattern can also change over time. A gallstone blocking the common bile duct may start with pain and rising AST or ALT, then later show rising ALP, GGT, and bilirubin. Acute hepatitis may cause very high ALT and AST first, while bilirubin rises later if inflammation disrupts bilirubin processing. Alcohol-related liver injury may show AST higher than ALT, but that pattern is not enough by itself to diagnose alcohol-related disease. For more detail on enzyme comparisons, ALT vs AST patterns can help explain why the ratio matters but does not provide a diagnosis alone.

High ALT and AST

ALT and AST are aminotransferase enzymes. They normally work inside cells, so higher blood levels often mean cells are irritated, inflamed, or damaged. ALT is more concentrated in the liver, making it more liver-specific than AST. AST is also present in skeletal muscle, heart, kidneys, brain, and red blood cells, so a high AST result needs broader context.

Mild ALT and AST elevations are common. One of the most frequent causes is fatty liver related to insulin resistance, higher waist circumference, type 2 diabetes, high triglycerides, sleep apnea, or metabolic syndrome. In that setting, ALT may be higher than AST early on. As fibrosis advances, AST can become equal to or higher than ALT, but the pattern varies.

Alcohol can raise AST, ALT, and GGT. In classic alcohol-related hepatitis, AST is often higher than ALT, and the AST/ALT ratio may be above 2. However, many people who drink heavily do not follow a textbook pattern, and other conditions can also affect the ratio. A high ratio should prompt honest alcohol history, medication review, and clinical assessment rather than a quick label. The combined pattern of AST/ALT ratio and GGT is often more informative than either marker alone.

Viral hepatitis is another important cause. Hepatitis A, B, C, and E can raise ALT and AST, sometimes dramatically. Acute viral hepatitis may cause fatigue, nausea, abdominal discomfort, dark urine, pale stools, jaundice, and very high aminotransferases. Chronic hepatitis B or C may cause mild, fluctuating, or even normal enzymes, so screening depends on risk factors and public health recommendations, not symptoms alone.

Medications and supplements deserve careful attention. Acetaminophen overdose can cause severe liver injury and very high ALT and AST. Other possible triggers include certain antibiotics, seizure medicines, statins, antifungal drugs, bodybuilding supplements, concentrated green tea extract, kava, and many herbal mixtures. This does not mean these products are always unsafe; it means abnormal LFTs should be interpreted with a complete list of prescription drugs, over-the-counter medicines, supplements, alcohol, and recent dose changes. When overdose or toxicity is possible, an acetaminophen level with liver enzymes may be urgent.

AST can rise from muscle injury. Heavy weightlifting, endurance events, seizures, trauma, injections, or rhabdomyolysis can raise AST and sometimes ALT. In those cases, creatine kinase, urine findings, kidney markers, and muscle symptoms help separate muscle injury from liver injury. A person with very sore muscles and high AST after extreme exercise may need a different evaluation than someone with jaundice and high ALT after a medication overdose.

Less common causes still matter when elevations persist or are unexplained. Autoimmune hepatitis, hereditary hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency, celiac disease, thyroid disease, and vascular liver conditions may be considered depending on age, family history, symptoms, and the pattern of results. Persistently high enzymes should not be dismissed simply because the elevation is mild.

High ALP, GGT, and Bilirubin

ALP and GGT help evaluate bile duct and cholestatic patterns. Bile is made in the liver and moves through small ducts inside the liver, then through larger ducts toward the gallbladder and intestine. When bile flow slows or ducts are irritated, ALP and GGT often rise.

ALP is useful but not liver-specific. It can come from the liver, bile ducts, bone, intestine, or placenta. That is why GGT is often checked when ALP is high. If ALP and GGT are both high, a liver or bile duct source becomes more likely. If ALP is high but GGT is normal, bone or another non-liver source becomes more likely. ALP isoenzyme testing may also help when the source is unclear, especially when bone disease, healing fracture, vitamin D problems, or liver disease could all fit. A more focused discussion of ALP and GGT patterns can be useful when these two markers disagree.

High ALP with high bilirubin can suggest a blocked or inflamed bile drainage system. Gallstones are a common cause, especially when results occur with right upper abdominal pain, nausea, vomiting, fever, or jaundice. Other causes include bile duct strictures, pancreatitis-related swelling, primary biliary cholangitis, primary sclerosing cholangitis, tumors near the bile duct, and certain medication reactions.

GGT can rise with alcohol use, fatty liver, bile duct disease, many medications, and smoking. It is sensitive but not specific. A high GGT alone does not prove alcohol misuse or serious liver disease. It should be read with ALT, AST, ALP, bilirubin, symptoms, and risk factors. A high GGT with high ALP is more helpful because it supports a liver or bile duct source for ALP.

Bilirubin adds another layer. Total bilirubin is often divided into direct and indirect fractions. Indirect bilirubin rises when the body makes more bilirubin than the liver can process, or when conjugation is reduced. Hemolysis and Gilbert syndrome are common examples. Gilbert syndrome is a benign inherited pattern that can cause intermittent mild indirect bilirubin elevation, often triggered by fasting, illness, dehydration, or stress.

Direct bilirubin rises when the liver has conjugated bilirubin but cannot move it normally into bile, or when injured liver cells leak it back into blood. High direct bilirubin can occur with hepatitis, cirrhosis, medication injury, bile duct obstruction, and cholestatic liver diseases. When bilirubin is high enough, the skin and eyes may turn yellow, urine may become dark, and stools may become pale or clay-colored. The difference between direct and indirect bilirubin can narrow the list of likely causes.

Bilirubin results need symptoms. Mild isolated indirect bilirubin in a well person may be monitored or evaluated calmly. New jaundice with abdominal pain, fever, confusion, easy bleeding, or very abnormal enzymes is different and needs urgent medical care.

Albumin and True Liver Function

Albumin is one of the most important proteins in the blood. The liver makes it, and the body uses it to keep fluid inside blood vessels, transport hormones and medicines, and maintain normal pressure between the bloodstream and tissues. Because albumin is made by the liver, it is often included in liver panels.

Low albumin can suggest chronic liver disease, especially when it appears with other signs such as high bilirubin, high INR, low platelets, fluid in the abdomen, leg swelling, or imaging evidence of cirrhosis. In advanced liver scarring, the liver may lose enough working capacity that albumin production falls.

Albumin is not a quick injury marker. It has a relatively long half-life, so it may stay normal during early or acute liver injury. A person can have very high ALT and AST from acute hepatitis while albumin remains normal. By contrast, low albumin often suggests a longer-running process, severe systemic illness, or protein loss outside the liver.

Many non-liver causes can lower albumin. Kidney disease can allow albumin to leak into urine. Severe inflammation can shift albumin out of the bloodstream and reduce production. Poor protein intake, malabsorption, burns, major infection, heart failure, and protein-losing intestinal conditions can also lower albumin. That is why albumin should be interpreted with urine protein testing, kidney function, inflammatory markers, nutrition status, physical findings, and the rest of the liver panel.

Albumin also interacts with swelling patterns. Low albumin reduces oncotic pressure, which is one force that helps keep fluid inside blood vessels. When albumin is low, fluid may collect in the legs, abdomen, or other tissues. In liver disease, swelling may also involve portal hypertension, sodium retention, kidney hormone changes, and low albumin together.

PT/INR is another important function marker. The liver makes clotting factors, and PT/INR can rise when clotting factor production falls. A high INR in someone not taking warfarin can be more urgent than mild enzyme elevation because it may suggest impaired synthetic function, vitamin K deficiency, severe cholestasis, or acute liver failure. Albumin and INR are often interpreted together, as in liver synthetic function patterns.

What to Do After Abnormal LFTs

The next step after abnormal LFTs depends on the pattern, degree of elevation, symptoms, medical history, and whether the abnormality is new or persistent. A single mild abnormality is common, but it still deserves thoughtful review.

First, compare the results with prior labs. A stable ALT of 48 U/L for several years is different from a jump from 24 to 220 U/L in one month. Trends show whether the issue is improving, worsening, fluctuating, or persistent. Bring older results when seeing a clinician, especially if testing was done at different labs.

Second, review exposures. This includes alcohol, acetaminophen, antibiotics, seizure medicines, statins, antifungals, hormones, bodybuilding products, weight-loss supplements, herbal extracts, recreational drugs, and occupational or environmental toxins. Include products that feel “natural.” Natural products can still affect the liver, and many supplements contain mixtures that are hard to trace.

Third, match the pattern to likely follow-up tests. A hepatocellular pattern may lead to hepatitis testing, metabolic risk assessment, iron studies, autoimmune markers, and ultrasound. A cholestatic pattern may lead to repeat ALP with GGT, bilirubin fractionation, ultrasound, and sometimes bile duct imaging. Low albumin may lead to urine protein testing, kidney evaluation, nutrition assessment, inflammatory markers, and INR.

Fourth, address common reversible factors while evaluation is underway. Avoid heavy alcohol use, do not exceed recommended acetaminophen doses, and do not combine acetaminophen with alcohol. Pause nonessential supplements only after discussing the situation with a clinician, especially if the product may be contributing. For suspected fatty liver, improvements in weight, waist circumference, glucose control, triglycerides, sleep apnea, and physical activity can improve liver enzymes and long-term risk.

Fifth, repeat testing when appropriate. If results are only mildly abnormal and there are no red flags, clinicians may repeat the panel after a short interval, often a few weeks to a few months, depending on the situation. Repeating too soon after a known trigger may create confusion; waiting too long when bilirubin, INR, or symptoms are concerning can be unsafe.

Finally, use imaging and fibrosis assessment when risk is meaningful. Ultrasound can detect fatty liver, gallstones, bile duct dilation, masses, and some cirrhosis features, though it cannot rule out all liver disease. Elastography can estimate liver stiffness. Blood-based fibrosis scores may combine age, AST, ALT, platelet count, and other markers to estimate the chance of advanced fibrosis. If ferritin is also elevated, the pattern of high ferritin with liver enzymes can help separate inflammation, fatty liver, alcohol-related injury, and iron overload.

When Results Need Urgent Care

Some liver test results can wait for routine follow-up, but certain patterns need prompt medical attention. The danger is not only the enzyme number. Symptoms and function markers often matter more.

Seek urgent care for jaundice that appears suddenly, especially with dark urine, pale stools, fever, severe right upper abdominal pain, vomiting, confusion, fainting, severe weakness, easy bruising, bleeding, or a swollen abdomen. These symptoms can occur with bile duct obstruction, acute hepatitis, severe infection, pancreatitis, liver failure, or other serious conditions.

Very high ALT or AST also needs fast evaluation. Levels in the hundreds can be significant, and levels in the thousands can occur with acute viral hepatitis, acetaminophen toxicity, ischemic liver injury from poor blood flow, severe drug-induced liver injury, or other acute liver cell damage. Timing matters because some treatments work best early.

A high INR in someone not taking anticoagulants is another red flag, especially with confusion, jaundice, low blood sugar, or severe illness. INR can reflect clotting factor production, and worsening INR during acute liver injury may suggest that the liver is not keeping up with essential protein production.

High bilirubin with high ALP and GGT may suggest impaired bile flow. If this occurs with fever and abdominal pain, clinicians worry about infection in the bile ducts, which can become dangerous quickly. If it occurs with weight loss, persistent itching, pale stools, or painless jaundice, evaluation for obstruction or serious bile duct and pancreatic conditions is important.

Children, pregnant people, older adults, and people with known cirrhosis or immune suppression may need lower thresholds for medical care. In pregnancy, itching with abnormal bile acids or liver tests can suggest pregnancy-specific liver conditions. In known cirrhosis, new confusion, vomiting blood, black stools, fever, severe abdominal swelling, or kidney changes are urgent even if enzyme elevations are not dramatic.

For nonurgent abnormalities, the safest approach is steady follow-up rather than panic or dismissal. Many LFT changes are treatable or reversible once the cause is found. The panel becomes most useful when it is read as a pattern, checked over time, and connected to the person’s symptoms, risks, medications, and overall health.

References

• Liver Function Tests 2023 (Official Medical Test Resource)
• ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries 2017 (Guideline)
• Guidelines on the management of abnormal liver blood tests 2018 (Guideline)
• Gamma-glutamyl Transferase (GGT) Test 2024 (Official Medical Test Resource)
• Bilirubin Blood Test 2024 (Official Medical Test Resource)
• Albumin Blood Test 2024 (Official Medical Test Resource)

Disclaimer

Liver function test results should be interpreted by a qualified health professional who can review your symptoms, medications, alcohol use, medical history, and prior results. This article is for general education and does not diagnose liver disease or replace medical care. Seek urgent medical help for jaundice with confusion, bleeding, severe abdominal pain, fever, fainting, or suspected overdose.